Indian Pharmaceutical Sector - Overview & Investment Analysis 2026
Comprehensive analysis of the Indian pharma sector - 12-company comparison table, India vs global valuation, US Section 232 tariff risk, patent cliff/GLP-1 opportunity, and an investment timing verdict.